302 related articles for article (PubMed ID: 35168419)
1. Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma).
Cotter JA; Judkins AR
Pediatr Dev Pathol; 2022; 25(1):34-45. PubMed ID: 35168419
[TBL] [Abstract][Full Text] [Related]
2. Embryonal tumors in the WHO CNS5 classification: A Review.
Gianno F; Miele E; Antonelli M; Giangaspero F
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
[TBL] [Abstract][Full Text] [Related]
3. Embryonal Tumors of the Central Nervous System: An Update.
Blessing MM; Alexandrescu S
Surg Pathol Clin; 2020 Jun; 13(2):235-247. PubMed ID: 32389264
[TBL] [Abstract][Full Text] [Related]
4. Embryonal Tumors of the Central Nervous System with Multilayered Rosettes and Atypical Teratoid/Rhabdoid Tumors.
Kamenova M; Kaneva R; Genova K; Gabrovsky N
Adv Exp Med Biol; 2023; 1405():225-252. PubMed ID: 37452940
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
Cole BL; Pierson CR
Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
[TBL] [Abstract][Full Text] [Related]
6. Brain and Spinal Cord Tumors of Embryonic Origin.
Lampros M; Alexiou GA
Adv Exp Med Biol; 2023; 1405():405-420. PubMed ID: 37452947
[TBL] [Abstract][Full Text] [Related]
7. Foxr2 promotes formation of CNS-embryonal tumors in a Trp53-deficient background.
Poh B; Koso H; Momota H; Komori T; Suzuki Y; Yoshida N; Ino Y; Todo T; Watanabe S
Neuro Oncol; 2019 Aug; 21(8):993-1004. PubMed ID: 30976792
[TBL] [Abstract][Full Text] [Related]
8. Embryonal Tumors of the Central Nervous System: From the Radiologic Pathology Archives.
Shih RY; Koeller KK
Radiographics; 2018; 38(2):525-541. PubMed ID: 29528832
[TBL] [Abstract][Full Text] [Related]
9. LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT).
Rao S; Rajeswarie RT; Chickabasaviah Yasha T; Nandeesh BN; Arivazhagan A; Santosh V
Childs Nerv Syst; 2017 Nov; 33(11):1953-1959. PubMed ID: 28744687
[TBL] [Abstract][Full Text] [Related]
10. Current Open Trials and Molecular Update for Pediatric Embryonal Tumors.
Rosenberg T; Cooney T
Pediatr Neurosurg; 2023; 58(5):299-306. PubMed ID: 37245504
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.
von Hoff K; Haberler C; Schmitt-Hoffner F; Schepke E; de Rojas T; Jacobs S; Zapotocky M; Sumerauer D; Perek-Polnik M; Dufour C; van Vuurden D; Slavc I; Gojo J; Pickles JC; Gerber NU; Massimino M; Gil-da-Costa MJ; Garami M; Kumirova E; Sehested A; Scheie D; Cruz O; Moreno L; Cho J; Zeller B; Bovenschen N; Grotzer M; Alderete D; Snuderl M; Zheludkova O; Golanov A; Okonechnikov K; Mynarek M; Juhnke BO; Rutkowski S; Schüller U; Pizer B; von Zezschwitz B; Kwiecien R; Wechsung M; Konietschke F; Hwang EI; Sturm D; Pfister SM; von Deimling A; Rushing EJ; Ryzhova M; Hauser P; Łastowska M; Wesseling P; Giangaspero F; Hawkins C; Figarella-Branger D; Eberhart C; Burger P; Gessi M; Korshunov A; Jacques TS; Capper D; Pietsch T; Kool M
Neuro Oncol; 2021 Sep; 23(9):1597-1611. PubMed ID: 34077956
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathology of tumors of the central nervous system.
Kristensen BW; Priesterbach-Ackley LP; Petersen JK; Wesseling P
Ann Oncol; 2019 Aug; 30(8):1265-1278. PubMed ID: 31124566
[TBL] [Abstract][Full Text] [Related]
13. [Neuropathology of medulloblastomas and other CNS embryonal tumors : Precision diagnostics through the integration of genetic markers].
Pietsch T
Pathologe; 2019 Mar; 40(2):140-147. PubMed ID: 30790012
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.
Han YP; Ma CK; Wang SQ; Enomoto A; Zhao Y; Takahashi M; Ma J
J Neurooncol; 2014 Sep; 119(2):343-51. PubMed ID: 24879375
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastomas, CNS embryonal tumors, and cerebellar mutism syndrome: advances in care and future directions.
Patel N; Keating G; Solanki GA; Syed HR; Keating RF
Childs Nerv Syst; 2023 Oct; 39(10):2633-2647. PubMed ID: 37632526
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017.
Niehusmann P; Stensvold E; Leske H; Pietsch T; Goschzik T; Gielen GH; Due-Tønnessen B; Frič R; Nilssen Y; Brandal P
Pediatr Blood Cancer; 2022 Sep; 69(9):e29736. PubMed ID: 35570402
[TBL] [Abstract][Full Text] [Related]
17. A Practical Approach to the Evaluation and Diagnosis of Pediatric CNS Tumors.
Cotter JA; Viaene AN; Santi M; Hawkins C; Judkins AR
Pediatr Dev Pathol; 2022; 25(1):6-9. PubMed ID: 33872110
[TBL] [Abstract][Full Text] [Related]
18. CNS embryonal tumours: WHO 2016 and beyond.
Pickles JC; Hawkins C; Pietsch T; Jacques TS
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):151-162. PubMed ID: 28949028
[TBL] [Abstract][Full Text] [Related]
19. Embryonal Tumors of the Central Nervous System: The WHO 2016 Classification and New Insights.
Pinheiro JAF; de Almeida JCM; Lopes JMPB
J Pediatr Hematol Oncol; 2021 Apr; 43(3):79-89. PubMed ID: 32925406
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
